Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Samsung Biologics
Samsung Biologics
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
Danish pharmacies invest in hi-tech environmental monitoring system
The construction of a new building prompted one of Denmark’s largest pharmacy businesses to invest in Vaisala’s viewLinc Continuous Monitoring System (CMS) to protect the...
Industry 4.0: What is the advantage of real-time digital signage?
Olivia Fernandez from Digital Therapeutics (DTx) disusses how digital signage can serve in cleanrooms as a versatile and powerful tool that allows those in charge to ensure...
Scientific justification for monitoring indirect product contact surfaces
Findings from a survey on several pharma companies unveil the best practices for monitoring indirect product contact surfaces. Walid El Azab and Lillia Belkhamassi explain
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Pharmaceutical
Samsung Biologics selects company to automate microbiology QC testing
Samsung Biologics has selected Rapid Micro Biosystems’ Growth Direct platform to automate critical microbiology quality control testing
Sustainability
CDMO Samsung Biologics receives Terra Carta Seal for sustainable operations
The South Korean pharmaceutical CDMO has built an environmental management strategy that includes process optimisation, renewable energy transition, and minimising the use of single-use products
Pharmaceutical
Samsung Biologics appoints industry veteran as CEO
Samsung Biologics has announced John Rim as its President and CEO
Finance
Samsung Biologics plans $2bn 'Super Plant' for biomanufacturing
The company has also said that it is in negotiations with the authorities at Incheon Free Economic Zone to purchase additional land for its second bio complex
Pharmaceutical
Samsung BioLogics Plant 3 starts cGMP production
Facility in Incheon, South Korea, features 180,000L capacity, 20% more than its sister plant. The site passed validation in 10 months
Subscribe now